Patents by Inventor Christal Miller

Christal Miller has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Abuse-resistant hydrocodone compounds
    Patent number: 7338939
    Abstract: The present invention decreases the potential for abuse of opioids, particularly hydrocodone, by covalent modification. The invention provides methods of delivering hydrocodone as conjugates that release the hydrocodone following oral administration while being resistant to abuse by circuitous routes such as intravenous (“shooting”) injection and intranasal administration (“snorting”). Further, hydrocodone compositions of the invention are resistant to oral abuse as well, since release of the hydrocodone at suprapharmacological doses reaches saturation.
    Type: Grant
    Filed: September 30, 2004
    Date of Patent: March 4, 2008
    Assignee: New River Pharmaceuticals Inc.
    Inventors: Travis Mickle, Suma Krishnan, James Scott Moncrief, Christopher Lauderback, Christal Miller
  • Pharmaceutical compositions for prevention of overdose or abuse
    Publication number: 20070060500
    Abstract: The invention relates to pharmaceutical compositions comprised of a chemical moiety attached to an active agent in a manner that substantially decreases the potential of the active agent to cause overdose or to be abused. When delivered at the proper dosage the pharmaceutical composition provides therapeutic activity similar to that of the parent active agent.
    Type: Application
    Filed: March 30, 2006
    Publication date: March 15, 2007
    Applicant: New River Pharmaceuticals Inc.
    Inventors: Travis Mickle, Suma Krishnan, James Moncrief, Christopher Lauderback, Christal Miller, Thomas Piccariello
  • Abuse-resistant hydrocodone compounds
    Publication number: 20050266070
    Abstract: The present invention decreases the potential for abuse of opioids, particularly hydrocodone, by covalent modification. The invention provides methods of delivering hydrocodone as conjugates that release the hydrocodone following oral administration while being resistant to abuse by circuitous routes such as intravenous (“shooting”) injection and intranasal administration (“snorting”). Further, hydrocodone compositions of the invention are resistant to oral abuse as well, since release of the hydrocodone at suprapharmacological doses reaches saturation.
    Type: Application
    Filed: September 30, 2004
    Publication date: December 1, 2005
    Applicant: New River Pharmaceuticals Inc.
    Inventors: Travis Mickle, Suma Krishnan, James Moncrief, Christopher Lauderback, Christal Miller
  • Abuse-resistant hydrocodone compounds
    Publication number: 20050176645
    Abstract: The present invention decreases the potential for abuse of opioids, particularly hydrocodone, by covalent modification. The invention provides methods of delivering hydrocodone as conjugates that release the hydrocodone following oral administration while being resistant to abuse by circuitous routes such as intravenous (“shooting”) injection and intranasal administration (“snorting”). Further, hydrocodone compositions of the invention are resistant to oral abuse as well, since release of the hydrocodone at suprapharmacological doses reaches saturation.
    Type: Application
    Filed: September 30, 2004
    Publication date: August 11, 2005
    Applicant: New River Pharmaceuticals Inc.
    Inventors: Travis Mickle, Suma Krishnan, James Moncrief, Christal Miller, Christopher Lauderback, Thomas Piccariello
  • Pharmaceutical compositions for prevention of overdose or abuse
    Publication number: 20050176646
    Abstract: The invention relates to pharmaceutical compositions comprised of a chemical moiety attached to an active agent in a manner that substantially decreases the potential of the active agent to cause overdose or to be abused. When delivered at the proper dosage the pharmaceutical composition provides therapeutic activity similar to that of the parent active agent.
    Type: Application
    Filed: September 30, 2004
    Publication date: August 11, 2005
    Applicant: New River Pharmaceuticals Inc.
    Inventors: Travis Mickle, Suma Krishnan, James Moncrief, Christopher Lauderback, Christal Miller